Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights

    NEXT STORY
    TG Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results
    PREV STORY
    Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Griffin Health launches its frameless SRS program using C-RAD Catalyst HD with cBrain software

    author_avatar
    NASDAQ Market News

    Sarepta Therapeutics Announces First Quarter 2019 Financial Results and Recent Corporate Developments

    author_avatar
    NASDAQ Market News

    Dynavax Reports Fourth Quarter and Year End 2017 Financial Results

    HEPLISAV-B Launched in the United States Phase 2 Data in Two Immuno-oncology Programs Planned ...

    author_avatar
    NASDAQ Market News